Cognetivity Neurosciences Ltd (OP: CGNSF )

0.0100 +0.0036 (+56.25%)

Streaming Delayed Price Updated: 1:44 PM EDT, Oct 11, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	47,000
Open	0.0064
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.0064
Today's Range	0.0064 - 0.0100
52wk Range	0.0011 - 0.1179
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

AI-Powered Psychedelic Treatments: Special Status And Next-Gen Contests Winners

June 08, 2023

As psychedelics and AI travel their own development paths, here are some initiatives looking at ways of enhancing the former with the latter’s help.

Via Benzinga

UK-Based Psychedelics Ancillary Business Wraps Up $3M Funding Round

October 28, 2022

A tech company responsible for creating a clinical testing platform that uses AI and machine learning for the detection of earliest cognitive impairment signs, Cognetivity Neurosciences Ltd.

Via Benzinga

Performance

YTD	-26.47%	-26.47%
1 Month	+244.83%	+244.83%
3 Month	-30.56%	-30.56%
6 Month	-50.74%	-50.74%
1 Year	-89.07%	-89.07%

More News

Wellbeing Digital Sciences' Integrated Approach Aims To Capture Emerging Mental Health Tech And Psychedelics Market

February 08, 2022

Via Benzinga

Ketamine One Teams Up With Cognetivity Neurosciences To Study PTSD, Depression

December 02, 2021

Via Benzinga

Cognitive Assessment And Training Market Size Expected To Reach $15.65 Billion In 2028

May 04, 2021

Via FinancialNewsMedia

Cognetivity Neurosciences and InterSystems Partner to Fast-track Integration of Early Dementia Detection with Global Healthcare Systems

May 04, 2021

Via FinancialNewsMedia

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.